Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Richard Bruton will announce the jobs later today Fine Gael via Flickr/Creative Commons
waterford jobs

Eirgen to create 30 new pharma jobs in Waterford

The maker of cancer care drugs says the jobs will help support the research and production of a new range of products.

WATERFORD BASED DRUGS Manufacturer Eirgen is to create 30 new jobs, it will be announced today, Siliconrepublic.com reports.

The maker of cancer care drugs says the jobs will help support the research and production of a  new range of products, which already include high potency drugs for cancer treatment.

“We are delighted to announce an additional 30 new highly skilled jobs for Eirgen Pharma” said the company’s co-founder, Patsy Carney. “Our continuing export-led growth is a fantastic endorsement of the achievements made by our staff to date to help us continue to grow our business in over 40 countries worldwide.”

The Minister for Jobs, Enterprise and Innovation Richard Bruton will announce the creation of the jobs at the company’s Old Kilmeadan Road HQ in Waterford City, before attending a forum on jobs for the South-East in the city.

Eirgen was co-founded in 2004 by Tom Brennan and Patsy Carney, who were working the pharmaceutical sector in the city.

In April, a Saudi firm bought a 48 per cent stake in the company for €19 million.

€15 million made in new export contracts and alliances >

Your Voice
Readers Comments
10
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.